Vidcast:   https://www.instagram.com/p/DUl7k40j79N/

Hospitalized COVID patients have more than double the risk of developing thyroid disease compared with COVID-negative patients. A new study from NYC’s Montefiore Health System studied more than 400,000 patients with no prior thyroid disease and compared those who tested positive for COVID-19 with those who tested negative. Their results were just published in The Journal of Clinical Endocrinology & Metabolism.

The data for hospitalized CoVid patient demonstrated a 3-fold increase in hyperthyroidism, that is elevated thyroid activity, a 2-fold increase in hypothyroidism, that is reduced thyroid function, and an elevated risk for other thyroid disorders. Importantly, even non-hospitalized CoVid patients, many of whom are younger adults, have a 30–50% higher risk of thyroid disease.

The risk doesn’t appear immediately. Researchers found thyroid problems often emerged two or more years after infection, and continued rising beyond four years of follow-up.

The results of this study suggests that people who’ve had COVID-19, particularly those with severe cases, will benefit from long-term thyroid monitoring.

https://www.endocrinologyadvisor.com/news/covid-19-long-term-thyroid-dysfunction-risk/

https://academic.oup.com/jcem/advance-article-abstract/doi/10.1210/clinem/dgaf688/8403187?redirectedFrom=fulltext&login=false#xd_co_f=MjhjYzZiNWQtY2EzNS00ZDdlLWFmYjMtNjY2ZTFmNTY5MGNk~

#CoVid #thyroid #hospitalization